{"id":"https://openalex.org/W4224254969","doi":"https://doi.org/10.36266/ijed/135","title":"Improved HbA1c value by combined treatment of Dulaglutide and Imeglimin for patient with type 2 diabetes mellitus (T2DM)","display_name":"Improved HbA1c value by combined treatment of Dulaglutide and Imeglimin for patient with type 2 diabetes mellitus (T2DM)","publication_year":2022,"publication_date":"2022-02-28","ids":{"openalex":"https://openalex.org/W4224254969","doi":"https://doi.org/10.36266/ijed/135"},"language":"en","primary_location":{"id":"doi:10.36266/ijed/135","doi":"https://doi.org/10.36266/ijed/135","is_oa":false,"landing_page_url":"https://doi.org/10.36266/ijed/135","pdf_url":null,"source":{"id":"https://openalex.org/S4387278337","display_name":"International Journal of Endocrinology and Diabetes","issn_l":"2694-3875","issn":["2694-3875"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Endocrinology and Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://tokushima-u.repo.nii.ac.jp/records/2009804","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161115945","display_name":"Hiroshi Bando","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bando, Hiroshi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161017590","display_name":"M Okada","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Okada, M","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161081999","display_name":"N Iwatsuki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Iwatsuki, N","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161047507","display_name":"K Sakamoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sakamoto, K","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5160992031","display_name":"T Ogawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ogawa, T","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8247,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.68301611,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"5","issue":"1","first_page":"1","last_page":"4"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9879999756813049},{"id":"https://openalex.org/keywords/dulaglutide","display_name":"dulaglutide","score":0.9350000023841858},{"id":"https://openalex.org/keywords/imeglimin","display_name":"imeglimin","score":0.9869999885559082},{"id":"https://openalex.org/keywords/hba1c-reduction","display_name":"HbA1c reduction","score":0.8619999885559082},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7879999876022339},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.8690000176429749},{"id":"https://openalex.org/keywords/glucose-stimulated-insulin-secretion","display_name":"glucose-stimulated insulin secretion","score":0.8619999885559082},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.7179999947547913},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8360000252723694},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.8809999823570251},{"id":"https://openalex.org/keywords/mild-cognitive-impairment","display_name":"mild cognitive impairment","score":0.9309999942779541},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.6790000200271606}],"concepts":[{"id":"https://openalex.org/C2779829264","wikidata":"https://www.wikidata.org/wiki/Q21011228","display_name":"Dulaglutide","level":5,"score":0.9409972429275513},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.743696928024292},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6097742319107056},{"id":"https://openalex.org/C2776291640","wikidata":"https://www.wikidata.org/wiki/Q2912517","display_name":"Value (mathematics)","level":2,"score":0.4482182264328003},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4357350468635559},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.39179083704948425},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.371093213558197},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.1867029368877411},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.16461268067359924},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.12249857187271118},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.36266/ijed/135","doi":"https://doi.org/10.36266/ijed/135","is_oa":false,"landing_page_url":"https://doi.org/10.36266/ijed/135","pdf_url":null,"source":{"id":"https://openalex.org/S4387278337","display_name":"International Journal of Endocrinology and Diabetes","issn_l":"2694-3875","issn":["2694-3875"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Endocrinology and Diabetes","raw_type":"journal-article"},{"id":"pmh:oai:irdb.nii.ac.jp:00906:0006781698","doi":null,"is_oa":true,"landing_page_url":"https://tokushima-u.repo.nii.ac.jp/records/2009804","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Endocrinology and Diabetes","raw_type":"journal article"}],"best_oa_location":{"id":"pmh:oai:irdb.nii.ac.jp:00906:0006781698","doi":null,"is_oa":true,"landing_page_url":"https://tokushima-u.repo.nii.ac.jp/records/2009804","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Endocrinology and Diabetes","raw_type":"journal article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4405379685","https://openalex.org/W4388875278","https://openalex.org/W2324142099","https://openalex.org/W4301828135","https://openalex.org/W7207943493","https://openalex.org/W2944529529","https://openalex.org/W7223442281","https://openalex.org/W4320022142","https://openalex.org/W2316141605","https://openalex.org/W2951078022"],"abstract_inverted_index":{"Background:":[0],"As":[1],"a":[2,39,74],"novel":[3],"oral":[4],"hypoglycemic":[5],"agent":[6,49],"(OHA),":[7],"imeglimin":[8,123,158,181],"has":[9,24,38],"been":[10],"recently":[11],"applied":[12],"for":[13,47,90,145],"patients":[14],"with":[15,29,63],"type":[16],"2":[17],"diabetes":[18],"mellitus":[19],"(T2DM)":[20],"as":[21],"Twymeeg.":[22],"It":[23,37],"beneficial":[25],"twin":[26],"mechanisms":[27,156],"associated":[28],"increasing":[30],"insulin":[31,35,167],"secretion,":[32],"and":[33,42,65,85,100,117,124,140,182,189],"decreasing":[34],"resistance.":[36],"triazine":[40],"ring":[41],"become":[43],"the":[44,51,54,128,146,149,163,178,193],"first":[45],"OHA":[46],"tetrahydrotriazine-containing":[48],"in":[50,113,127],"category":[52],"of":[53,122,157,165,180],"glimins.":[55],"Case":[56],"presentation:":[57],"The":[58,184],"case":[59],"is":[60,186],"84-year-old":[61],"female":[62],"T2DM":[64],"mild":[66],"cognitive":[67],"impairment":[68],"(MCI).":[69],"Her":[70],"HbA1c":[71,88,94,107,132,175],"was":[72,79,95,103],"9.3%":[73],"year":[75],"ago.":[76],"Results:":[77],"She":[78],"begun":[80],"to":[81,98,111],"receive":[82],"Dulaglutide":[83],"0.75mg/week":[84],"showed":[86,134,173],"1.3%":[87],"reduction":[89,133,176],"6":[91],"months.":[92,115],"However,":[93],"elevated":[96],"again":[97],"8.5%,":[99],"then":[101],"she":[102,172],"provided":[104],"Twymeeg":[105],"2000mg/day.":[106],"decreased":[108],"from":[109],"8.5%":[110],"7.5%":[112],"3":[114],"[Discussion":[116],"conclusion]":[118],"From":[119],"combined":[120],"treatments":[121],"other":[125],"agents":[126],"previous":[129],"study,":[130],"mean":[131],"single":[135],"imiglimin":[136],"-0.46%,":[137],"DPP-4i":[138],"-0.92%":[139],"GLP-1RA":[141],"-0.12%.":[142],"Possible":[143],"reason":[144],"difference":[147],"between":[148],"latter":[150],"two":[151],"suggests":[152],"that":[153],"multiple":[154],"action":[155],"may":[159],"be":[160,197],"present":[161],"including":[162],"enhancement":[164],"glucose-stimulated":[166],"secretion":[168],"(GSIS).":[169],"In":[170],"contrast,":[171],"satisfactory":[174],"by":[177],"combination":[179],"GLP-1RA.":[183],"pathophysiology":[185],"not":[187],"clear,":[188],"future":[190],"follow":[191],"up":[192],"clinical":[194],"progress":[195],"will":[196],"required.":[198]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2022-04-26T00:00:00"}